Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Pharmacokinetics of Iodine and Fluoride following Application of an Anticaries Varnish in Adults.

Lin YS, Rothen ML, Milgrom P.

JDR Clin Trans Res. 2018 Jul;3(3):238-245. doi: 10.1177/2380084418771930. Epub 2018 Apr 25.

PMID:
30938600
2.

Randomized Trial Based on the Common-Sense Model of Self-regulation to Increase Child Dental Visits.

Nelson S, Milgrom P, Albert JM, Selvaraj D, Cunha-Cruz J, Curtan S, Copeland T, Heima M, Rothen M, Beck G, Ferretti G, Riedy C.

JDR Clin Trans Res. 2019 Feb 22:2380084419830662. doi: 10.1177/2380084419830662. [Epub ahead of print]

PMID:
30931720
3.

Pharmacokinetics of 38% topical silver diamine fluoride in healthy adult volunteers.

Lin YS, Rothen ML, Milgrom P.

J Am Dent Assoc. 2019 Mar;150(3):186-192. doi: 10.1016/j.adaj.2018.10.018.

PMID:
30803490
4.

Age-related heterogeneity in dental caries and associated risk factors in individuals with cystic fibrosis ages 6-20 years: A pilot study.

Chi DL, Rosenfeld M, Mancl L, Chung WO, Presland RB, Sarvas E, Rothen M, Alkhateeb A, McNamara S, Genatossio A, Virella-Lowell I, Milla C, Scott J.

J Cyst Fibros. 2018 Nov;17(6):747-759. doi: 10.1016/j.jcf.2018.06.009. Epub 2018 Jul 10.

5.

Topical silver diamine fluoride for dental caries arrest in preschool children: A randomized controlled trial and microbiological analysis of caries associated microbes and resistance gene expression.

Milgrom P, Horst JA, Ludwig S, Rothen M, Chaffee BW, Lyalina S, Pollard KS, DeRisi JL, Mancl L.

J Dent. 2018 Jan;68:72-78. doi: 10.1016/j.jdent.2017.08.015. Epub 2017 Sep 1.

6.

Efficacy evaluation of an anti-caries varnish: protocol for a phase II randomised controlled trial.

Milgrom P, Tut O, Rothen M, Mancl L, Gallen M, Tanzer JM.

BMJ Open. 2017 Jun 30;7(6):e017866. doi: 10.1136/bmjopen-2017-017866.

7.

Unstimulated Saliva-Related Caries Risk Factors in Individuals with Cystic Fibrosis: A Cross-Sectional Analysis of Unstimulated Salivary Flow, pH, and Buffering Capacity.

Alkhateeb AA, Mancl LA, Presland RB, Rothen ML, Chi DL.

Caries Res. 2017;51(1):1-6. doi: 10.1159/000450658. Epub 2016 Nov 16.

8.

[Serious Headache].

Grünig B, Rothen M, Laube M.

Praxis (Bern 1994). 2016 Mar 16;105(6):339-42. doi: 10.1024/1661-8157/a002304. German.

PMID:
26980685
9.

Oral hygiene behaviors and caries experience in Northwest PRECEDENT patients.

Rothen M, Cunha-Cruz J, Zhou L, Mancl L, Jones JS, Berg J; Northwest PRECEDENT network.

Community Dent Oral Epidemiol. 2014 Dec;42(6):526-35. doi: 10.1111/cdoe.12107. Epub 2014 Apr 27.

10.

Tooth wear and the role of salivary measures in general practice patients.

Ramsay DS, Rothen M, Scott JM, Cunha-Cruz J; Northwest PRECEDENT network.

Clin Oral Investig. 2015 Jan;19(1):85-95. doi: 10.1007/s00784-014-1223-4. Epub 2014 Mar 20.

11.

A prospective study of clinical outcomes related to third molar removal or retention.

Huang GJ, Cunha-Cruz J, Rothen M, Spiekerman C, Drangsholt M, Anderson L, Roset GA.

Am J Public Health. 2014 Apr;104(4):728-34. doi: 10.2105/AJPH.2013.301649. Epub 2014 Feb 13.

12.

Recommendations for third molar removal: a practice-based cohort study.

Cunha-Cruz J, Rothen M, Spiekerman C, Drangsholt M, McClellan L, Huang GJ; Northwest Practice-Based Research Collaborative in Evidence-Based Dentistry.

Am J Public Health. 2014 Apr;104(4):735-43. doi: 10.2105/AJPH.2013.301652. Epub 2014 Feb 13.

13.

Per oral substitution with 300000 IU vitamin D (Cholecalciferol) reduces bone turnover markers in HIV-infected patients.

Piso RJ, Rothen M, Rothen JP, Stahl M, Fux C.

BMC Infect Dis. 2013 Dec 6;13:577. doi: 10.1186/1471-2334-13-577.

14.

Salivary characteristics and dental caries: evidence from general dental practices.

Cunha-Cruz J, Scott J, Rothen M, Mancl L, Lawhorn T, Brossel K, Berg J; Northwest Practice-based REsearch Collaborative in Evidence-based DENTistry.

J Am Dent Assoc. 2013 May;144(5):e31-40.

15.

The prevalence of dentin hypersensitivity in general dental practices in the northwest United States.

Cunha-Cruz J, Wataha JC, Heaton LJ, Rothen M, Sobieraj M, Scott J, Berg J; Northwest Practice-based Research Collaborative in Evidence-based DENTistry.

J Am Dent Assoc. 2013 Mar;144(3):288-96.

16.

Randomized controlled trial assessing efficacy and safety of glycine powder air polishing in moderate-to-deep periodontal pockets.

Flemmig TF, Arushanov D, Daubert D, Rothen M, Mueller G, Leroux BG.

J Periodontol. 2012 Apr;83(4):444-52. doi: 10.1902/jop.2011.110367. Epub 2011 Aug 23.

PMID:
21861637
17.

Inter-examiner reliability of salivary diagnostic tests in a practice-based research network.

Rothen M, Cunha-Cruz J, Mancl L, Leroux B, Davis BL, Coyne J, Gillette J, Berg J.

J Dent Hyg. 2011 Spring;85(2):143-50. Epub 2011 May 16.

18.

Markers of bone turnover are elevated in patients with antiretroviral treatment independent of the substance used.

Piso RJ, Rothen M, Rothen JP, Stahl M.

J Acquir Immune Defic Syndr. 2011 Apr;56(4):320-4. doi: 10.1097/QAI.0b013e31820cf010.

PMID:
21350365
19.

What's in a dental practice-based research network? Characteristics of Northwest PRECEDENT dentists, their patients and office visits.

DeRouen TA, Cunha-Cruz J, Hilton TJ, Ferracane J, Berg J, Zhou L, Rothen M; Northwest Practice-based REsearch Collaborative in Evidence-based DENTistry (PRECEDENT).

J Am Dent Assoc. 2010 Jul;141(7):889-99.

20.

An Update from Northwest PRECEDENT (Practice-based REsearch Collaborative in Evidence-based DENTistry).

Rothen M.

J Dent Hyg. 2009 Fall;83(4):169-70. Epub 2009 Nov 2. No abstract available.

PMID:
19909631
21.

Xylitol and its vehicles for public health needs.

Milgrom P, Ly KA, Rothen M.

Adv Dent Res. 2009;21(1):44-7. doi: 10.1177/0895937409335623. Epub 2009 Jul 31. Review. No abstract available.

22.

The vaginal microflora in relation to gingivitis.

Persson R, Hitti J, Verhelst R, Vaneechoutte M, Persson R, Hirschi R, Weibel M, Rothen M, Temmerman M, Paul K, Eschenbach D.

BMC Infect Dis. 2009 Jan 22;9:6. doi: 10.1186/1471-2334-9-6.

23.

Xylitol gummy bear snacks: a school-based randomized clinical trial.

Ly KA, Riedy CA, Milgrom P, Rothen M, Roberts MC, Zhou L.

BMC Oral Health. 2008 Jul 25;8:20. doi: 10.1186/1472-6831-8-20.

24.

The potential of dental-protective chewing gum in oral health interventions.

Ly KA, Milgrom P, Rothen M.

J Am Dent Assoc. 2008 May;139(5):553-63. Review.

PMID:
18451371
25.

Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort.

Jenkins AJ, Rothen M, Klein RL, Moller K, Eldridge L, Zheng D, Durazo-Arvizu R, McGee D, Lackland D, Thorpe SR, Garvey WT, Lyons TJ; DCCT/EDIC Research Group.

J Diabetes Complications. 2008 May-Jun;22(3):153-63. doi: 10.1016/j.jdiacomp.2007.02.003. Epub 2008 Apr 16.

PMID:
18413218
26.

Tannerella forsythia and Pseudomonas aeruginosa in subgingival bacterial samples from parous women.

Persson GR, Hitti J, Paul K, Hirschi R, Weibel M, Rothen M, Persson RE.

J Periodontol. 2008 Mar;79(3):508-16. doi: 10.1902/jop.2008.070350 .

PMID:
18315434
27.

Multifocal thrombophlebitis and deep vein thrombosis in primary cytomegalovirus infection--a histopathological analysis.

Jeanneret C, Reutlinger C, Hirsch HH, Cathomas G, Rothen M, Martius F, Biedermann BC.

Thromb Haemost. 2008 Feb;99(2):445-7. doi: 10.1160/TH07-06-0413. No abstract available.

PMID:
18278199
28.

A surrogate method for comparison analysis of salivary concentrations of Xylitol-containing products.

Riedy CA, Milgrom P, Ly KA, Rothen M, Mueller G, Hagstrom MK, Tolentino E, Zhou L, Roberts MC.

BMC Oral Health. 2008 Feb 11;8:5. doi: 10.1186/1472-6831-8-5.

29.

Intravitreal triamcinolone for the treatment of diabetic macular edema.

Gómez-Ulla F, Marticorena J, Alfaro DV 3rd, Fernández M, Méndez ER, Rothen M.

Curr Diabetes Rev. 2006 Feb;2(1):99-112. Review.

PMID:
18220620
30.

Developing Public Health Interventions with Xylitol for the US and US-Associated Territories and States.

Milgrom P, Rothen M, Milgrom L.

Suom Hammaslaakarilehti. 2006 May 15;13(10-11):2-11.

31.

Xylitol, sweeteners, and dental caries.

Ly KA, Milgrom P, Rothen M.

Pediatr Dent. 2006 Mar-Apr;28(2):154-63; discussion 192-8. Review.

PMID:
16708791
32.
33.

Mutans streptococci dose response to xylitol chewing gum.

Milgrom P, Ly KA, Roberts MC, Rothen M, Mueller G, Yamaguchi DK.

J Dent Res. 2006 Feb;85(2):177-81.

34.

Anti-macular degeneration agents.

Rothen M, Jablon E, Monares G, Fontal MR, Alfaro DV 3rd.

Ophthalmol Clin North Am. 2005 Dec;18(4):561-7. Review.

PMID:
16314219
35.

Nitrous oxide analgesia in humans: acute and chronic tolerance.

Ramsay DS, Leroux BG, Rothen M, Prall CW, Fiset LO, Woods SC.

Pain. 2005 Mar;114(1-2):19-28.

36.

Obstructive jaundice caused by enteropathy-associated T-cell lymphoma in a patient with celiac sprue.

Buess M, Steuerwald M, Wegmann W, Rothen M.

J Gastroenterol. 2004 Nov;39(11):1110-3.

PMID:
15580407
37.

Eosinophilic meningitis due to Angiostrongylus cantonensis in Switzerland.

Bärtschi E, Bordmann G, Blum J, Rothen M.

Infection. 2004 Apr;32(2):116-8.

PMID:
15057577
38.

Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland.

Garbino J, Sommer R, Gerber A, Regamey C, Vernazza P, Gennè D, Dür P, Rothen M, Unger JP, Lew D.

Int J Infect Dis. 2002 Dec;6(4):288-93.

39.

Simultaneous bilateral spontaneous pneumothorax in a patient with recurrent, extraosseous multiple myeloma.

Peters F, Cathomas G, Rothen M, Thurnheer R, Rutishauser J.

Postgrad Med J. 2003 Feb;79(928):106-7.

40.

A case report: arresting dental caries.

Milgrom P, Rothen M, Spadafora A, Skaret E.

J Dent Hyg. 2001 Summer;75(3):241-3.

PMID:
11603306
41.

Improvement in immune function due to treatment with indinavir despite severe immune deficiency.

Rothen M, Bisset LR, Joller-Jemelka HI, Grob P, Lüthy R, Opravil M.

Antivir Ther. 1998;3(3):159-67.

PMID:
10682133
42.

Apoptosis in HIV-infected individuals is an early marker occurring independently of high viremia.

Rothen M, Gratzl S, Hirsch HH, Moroni C.

AIDS Res Hum Retroviruses. 1997 Jun 10;13(9):771-9.

PMID:
9171221
43.

Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma.

Böni J, Opravil M, Tomasik Z, Rothen M, Bisset L, Grob PJ, Lüthy R, Schüpbach J.

AIDS. 1997 May;11(6):F47-52.

PMID:
9143600
44.

Pain control in recovering alcoholics: effects of local anesthesia.

Fiset L, Leroux B, Rothen M, Prall C, Zhu C, Ramsay DS.

J Stud Alcohol. 1997 May;58(3):291-6.

PMID:
9130221
46.

The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells.

Gehri R, Hahn S, Rothen M, Steuerwald M, Nuesch R, Erb P.

AIDS. 1996 Jan;10(1):9-16.

PMID:
8924258

Supplemental Content

Loading ...
Support Center